Page last updated: 2024-08-17

levodopa and Psychoses, Drug

levodopa has been researched along with Psychoses, Drug in 125 studies

Research

Studies (125)

Timeframe	Studies, this research(%)	All Research%
pre-1990	49 (39.20)	18.7374
1990's	32 (25.60)	18.2507
2000's	31 (24.80)	29.6817
2010's	11 (8.80)	24.3611
2020's	2 (1.60)	2.80

Authors

Authors	Studies
Beaudry, F; Bédard, D; Gaudette, F; Gourdon, JC; Hamadjida, A; Huot, P; Michaud, V; Nuara, SG; Panisset, M; Sid-Otmane, L	1
Bédard, D; Frouni, I; Gourdon, JC; Hamadjida, A; Huot, P; Kwan, C; Nuara, SG	2
Espay, AJ; Espay, KJ; Fasano, A; Krikorian, R; Ricciardi, L	1
Bokor, M; Györfi, O; Kelemen, O; Kéri, S; Nagy, H	1
Frouni, I; Gourdon, JC; Hamadjida, A; Harraka, MJ; Huot, P; Kwan, C; Nuara, SG; Sid-Otmane, L; Veyres, N	1
Cardoso, F; Gomide, L; Kummer, A; Teixeira, AL	1
Baunez, C; Bezard, E; Fernagut, PO; Juncos, JL; Obeso, JA; Pavon, N; Rodriguez, M; Voon, V; Wickens, J	1
Gabriel, D; Guggisberg, A; Morand, S; Nahum, L; Schnider, A	1
Brotchie, JM; Fox, SH	1
Bartolini, WP; Brotchie, JM; Fox, SH; Huot, P; Johnston, TH; Milne, GT; Pearson, JP; Sykes, KA; Wakefield, JD	1
Inoue, M; Inoue, Y; Kishimoto, T; Kiuchi, K; Kosaka, J; Morikawa, M; Norimoto, K	1
Barbe, MT; Eggers, C; Pauls, KA; Salimi Dafsari, H; Timmermann, L	1
Chacón, JR; Mata, M	1
Brotchie, JM; Fox, SH; Huot, P; Jarvie, K; Koprich, JB; Lang, AE; Seeman, P	1
Factor, SA; Feustel, PJ; Molho, ES; Reddy, S	1
Gertz, HJ; Hermann, W; Müller, U; Reuter, M	1
Gupta, N; Malhotra, P	1
Hagenah, J; Kömpf, D; Moser, A	1
Brockmöller, J; Gasser, T; Grapengiesser, A; Hofer, A; Kaiser, R; Kupsch, A; Roots, I	1
Kodama, R; Kondo, T; Miwa, H; Morita, S	1
Goto, S; Ushio, Y; Yamada, K	1
Evatt, ML; Jewart, RD; Jou, HC; Juncos, JL; Potter, LS; Roberts, VJ; Wood, CD; Yeung, PP	1
Connemann, BJ; Schönfeldt-Lecuona, C	2
Foster, HD; Hoffer, A	1
Kostić, VS	1
Bourdeix, I; Destée, A; Durif, F; Péré, JJ; Pollak, P; Rascol, O; Senard, JM; Tison, F	1
Argyriou, AA; Ellul, J; Papapetropoulos, S	1
Aydemir, T; Aydin, B; Hanoglu, L; Meral, H; Oral, T; Ozer, F	1
Meixensberger, J; Preul, C; Schwarz, J; Strecker, K; Tittgemeyer, M; Winkler, D	1
Borek, LL; Friedman, JH	1
Schindehütte, J; Trenkwalder, C	1
Harn, HJ; Lin, JJ; Lin, SZ; Liu, JT; Yueh, KC	1
Duggal, HS; Singh, I	1
Goto, S; Hamasaki, T; Kuratsu, JI; Yamada, K	1
Delmas, G; Flesch, F; Rothmann, C	1
van der Zee, HJ; van Nieuwenhuizen, O; Zweije-Hofman, IL	1
Blair, RD; Lang, AE	1
Birkmayer, W; Danielczyk, W; Riederer, P	1
Klawans, HL	2
Fischer, PA; Grotz, A; Jacobi, P; Schneider, E	1
Goldstein, M; Goodgold, A; Gopinathan, G; Leibowitz, M; Lieberman, AN; Neophytides, A; Pact, V; Walker, R	1
Kaplan, LR; Klawans, HL; Nausieda, PA; Weber, S; Weiner, WJ	1
Beasley, BL; Chase, TN; Davenport, RW; Nutt, JG	1
Heinz, A; Pietzcker, A; Przuntek, H; Winterer, G	1
Greene, P	1
Dai, J; Kennedy, J; Meltzer, HY; Parsa, M; Riley, D	1
Brown, D; Factor, SA; Molho, ES; Podskalny, GD	1
Chouinard, G; Miller, R	1
Arnold, G; Oertel, WH; Schwarz, J; Trenkwalder, C	1
Friedman, A	1
Glosser, DS; Hurtig, H; Kim, E; McAllister, TW; Stern, M; Zwil, AS	1
George, A; Gray, P; Grimes, JD; Mendis, T; Mohr, E; Rusk, IN	1
Marder, K; Mayeux, R; Stern, Y; Tang, MX	1
Cote, L; Fahn, S; Greene, P	1
Carey, RJ; Dai, H; Huston, JP; Pinheiro-Carrera, M; Tomaz, C	1
Friedberg, G; Melamed, E; Weizmann, A; Ziv, I; Zoldan, J	1
Damecour, CL; Turcotte, JR	1
Klockgether, T; Spieker, S; Stetter, F	1
Angus, C; Lang, AE; Sandor, P; Singal, S	1
Brunt, E; Eichhorn, TE; Oertel, WH	1
Camicioli, R; Ganzini, L; Young, BK	1
Burke, WJ; McArthur-Campbell, D; Pfeiffer, RF; Widman, LP	1
Alessandri, A; Bonifati, V; Giustini, P; Meco, G	1
Berger, M; Frauenknecht, S; Hesslinger, B; Normann, C; Walden, J	1
Seeman, P; Tallerico, T	1
Bermejo Pareja, F; Fernández Ponsatí, JT; García-Escrig, M	1
Fernandez, HH; Friedman, JH; Jacques, C; Rosenfeld, M	1
Sunohara, N	1
Factor, SA; Molho, ES	1
Minagar, A; Shulman, LM; Weiner, WJ	1
Fernandez, HH	1
Kanazawa, I; Momose, Y; Murata, M	1
Brüne, M; Gerlach, G; Schröder, SG	1
Alvarez, M; Chacón, JR; Durán, E; Durán, JA	1
Seeman, P	1
Burke, MA; Fernandez, HH; Friedman, JH; Trieschmann, ME	1
Trimble, M	1
Danielczyk, W	2
Przuntek, H	1
Klawans, HL; Lupton, MD; Moskovitz, C; Sharf, B	1
Klawans, H	1
Reus, VI	1
Pearce, I; Pearce, JM	1
Antoncić, N; Ledić, P; Sepcić, J	1
Klawans, HL; Moses, H; Moskovitz, C	1
Klerman, GL; Krauthammer, C	1
Gerlach, J	1
Hayek, J	1
Braden, W	1
Angrist, B; Gershon, S	1
Snyder, SH	1
Lin, JT; Ziegler, DK	1
Gulmann, NC	1
Piccirilli, M; Quartesan, R	1
Girke, W; Xenakis, Ch	1
Klawans, HL; Margolin, DI	1
Birkmayer, W; Danielczyk, W; Neumayer, E; Riederer, P	1
Birkmayer, W; Riederer, P	1
Angrist, B; Gershon, S; Shopsin, B	1
Luchins, D	1
Holmsen, R	1
Gulmann, NC; Korsgaard, S	1
Brown, D; Factor, SA	1
Andersson, U; Aquilonius, SM; Freccero-Rosman, K; Lindvall, O; Nylander, B; Odin, P	1
Fenton, ML; Harnett, DS; Rosenthal, SH	1
Friedman, JH	1
Friedman, A; Sienkiewicz, J	1
Caraceni, T; Geminiani, G; Genitrini, S; Giovannini, P; Girotti, F; Piccolo, I; Scigliano, G; Soliveri, P	1
Artieda, J; Grandas, F; Lera, G; Luquin, MR; Martinez-Lage, JM; Obeso, JA; Rodriguez, ME; Vaamonde, J	1
Fahn, S	1
Dichgans, J; Scholz, E	1
Coleman, R; Critchley, P; Grandas Perez, F; Marsden, CD; Parkes, D; Quinn, N	1
De Cuypere, G; Jannes, C; Remouchamps, A; Tack, E	1
Demling, J	1
Critchley, P; Parkes, D	1
Feldman, RG; Lannon, MC	1
Morris, JG	1
Fischer, GJ; Quandt, J; Sommer, H	1
Cotzias, GC	1
Feldman, RD; Pearlman, CA; Sax, DS	1

Reviews

20 review(s) available for levodopa and Psychoses, Drug

Article	Year
Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders. The Lancet. Neurology, 2009, Volume: 8, Issue:12 Topics: Antiparkinson Agents; Automatism; Compulsive Behavior; Disruptive, Impulse Control, and Conduct Disorders; Dopamine; Dopamine Agents; Dyskinesia, Drug-Induced; Gambling; Humans; Levodopa; Parkinson Disease; Psychoses, Substance-Induced; Sexual Behavior	2009
The MPTP-lesioned non-human primate models of Parkinson's disease. Past, present, and future. Progress in brain research, 2010, Volume: 184 Topics: alpha-Synuclein; Animals; Antiparkinson Agents; Basal Ganglia; Cognition Disorders; Disease Models, Animal; Dopamine; Drug Discovery; Endpoint Determination; Humans; Levodopa; Movement; MPTP Poisoning; Neurons; Neuroprotective Agents; Parkinson Disease, Secondary; Primates; Psychoses, Substance-Induced; Sleep Wake Disorders	2010
[Parkinson's disease: current standards in diagnostics and therapy]. Fortschritte der Neurologie-Psychiatrie, 2012, Volume: 80, Issue:10 Topics: Antidepressive Agents; Antiparkinson Agents; Deep Brain Stimulation; Disruptive, Impulse Control, and Conduct Disorders; Drug Implants; Gait Disorders, Neurologic; Humans; Levodopa; Parkinson Disease; Psychoses, Substance-Induced; Tremor	2012
[Candidate patient for subcutaneous apomorphine injection]. Revista de neurologia, 2012, Volume: 55 Suppl 1 Topics: Abnormalities, Drug-Induced; Antiparkinson Agents; Apomorphine; Contraindications; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hypotension, Orthostatic; Injections, Subcutaneous; Lactation; Levodopa; Parkinson Disease; Patient Selection; Pregnancy; Pregnancy Complications; Psychoses, Substance-Induced	2012
Comt inhibition in the treatment of Parkinson's disease: neuroprotection and future perspectives. Advances in experimental medicine and biology, 2004, Volume: 541 Topics: Animals; Antiparkinson Agents; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Depression; Dyskinesia, Drug-Induced; Forecasting; Humans; Levodopa; Neuroprotective Agents; Parkinson Disease; Psychoses, Substance-Induced	2004
Parkinson's disease in 1984: an update. Canadian Medical Association journal, 1984, Nov-01, Volume: 131, Issue:9 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aged; Animals; Dementia; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Levodopa; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Primates; Psychoses, Substance-Induced; Pyridines; Receptors, Dopamine; Time Factors	1984
Parkinson's disease: drug-induced psychiatric states. Advances in neurology, 1995, Volume: 65 Topics: Aged; Anxiety; Bipolar Disorder; Clozapine; Depression; Electroconvulsive Therapy; Humans; Levodopa; Lisuride; Male; Ondansetron; Parkinson Disease; Psychoses, Substance-Induced; Sexual Dysfunctions, Psychological	1995
Loss of striatal cholinergic neurons as a basis for tardive and L-dopa-induced dyskinesias, neuroleptic-induced supersensitivity psychosis and refractory schizophrenia. Biological psychiatry, 1993, Nov-15, Volume: 34, Issue:10 Topics: Antipsychotic Agents; Corpus Striatum; Dyskinesia, Drug-Induced; Humans; Interneurons; Levodopa; Nerve Degeneration; Neurons; Parkinson Disease; Psychoses, Substance-Induced; Receptors, Cholinergic; Receptors, Dopamine; Schizophrenia	1993
Involvement of serotonin in clinical features of Parkinson's disease and complications of L-DOPA therapy. Advances in neurology, 1996, Volume: 69 Topics: Antiparkinson Agents; Humans; Levodopa; Parkinson Disease; Psychoses, Substance-Induced; Serotonin	1996
Neuropsychiatric adverse effects of antiparkinsonian drugs. Characteristics, evaluation and treatment. Drugs & aging, 1997, Volume: 10, Issue:5 Topics: Aging; Akathisia, Drug-Induced; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Cholinergic Antagonists; Delirium; Dementia; Depression; Dopamine Agonists; Electroconvulsive Therapy; Humans; Levodopa; Memantine; Monoamine Oxidase Inhibitors; Psychoses, Substance-Induced; Risk Factors; Serotonin Antagonists	1997
Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors. Molecular psychiatry, 1998, Volume: 3, Issue:2 Topics: Antipsychotic Agents; Binding, Competitive; Cholinergic Antagonists; Clozapine; Corpus Striatum; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Resistance; Dyskinesia, Drug-Induced; Humans; Levodopa; Ligands; Limbic System; Nerve Tissue Proteins; Parkinson Disease, Secondary; Protein Binding; Psychoses, Substance-Induced; Psychotic Disorders; Radioligand Assay; Receptors, Dopamine D2; Receptors, Muscarinic; Receptors, Serotonin; Recurrence; Serotonin Antagonists; Tomography, Emission-Computed	1998
[Toxic and adverse neurological effects of anti-parkinsonian drugs]. Ryoikibetsu shokogun shirizu, 1999, Issue:27 Pt 2 Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Cholinergic Antagonists; Dopamine Agents; Dyskinesia, Drug-Induced; Humans; Levodopa; Neuroleptic Malignant Syndrome; Psychoses, Substance-Induced; Substance-Related Disorders	1999
[Treatment of advanced Parkinson's disease]. Nihon rinsho. Japanese journal of clinical medicine, 2000, Volume: 58, Issue:10 Topics: Antiparkinson Agents; Autonomic Nervous System Diseases; Dopamine Agents; Dopamine Agonists; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease; Psychoses, Substance-Induced; Severity of Illness Index	2000
Atypical antipsychotics: mechanism of action. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2002, Volume: 47, Issue:1 Topics: Antipsychotic Agents; Drug Administration Schedule; Humans; Levodopa; Neural Pathways; Parkinson Disease; Psychoses, Substance-Induced; Receptors, Dopamine D2; Receptors, Serotonin; Schizophrenia	2002
[Therapy of tparkinson's disease. Clinical and pharmacological viewpoints]. Medizinische Klinik, 1979, Jul-13, Volume: 74, Issue:28-29 Topics: Adrenergic beta-Antagonists; Amantadine; Bromocriptine; Histamine H1 Antagonists; Humans; Levodopa; Monoamine Oxidase Inhibitors; MSH Release-Inhibiting Hormone; Muscle Rigidity; Parasympatholytics; Parkinson Disease; Posture; Psychoses, Substance-Induced; Tremor	1979
Amine precursors in neurologic disorders and the psychoses. Research publications - Association for Research in Nervous and Mental Disease, 1975, Volume: 54 Topics: Acetylcholine; Corpus Striatum; Dopamine; Homovanillic Acid; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Levodopa; Movement Disorders; Nerve Degeneration; Parkinson Disease; Psychoses, Substance-Induced; Psychotic Disorders	1975
Bromocriptine in Parkinsonism. British medical journal, 1978, May-27, Volume: 1, Issue:6124 Topics: Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Psychoses, Substance-Induced	1978
[Side-effects of L-dopa therapy]. Deutsche medizinische Wochenschrift (1946), 1975, Oct-17, Volume: 100, Issue:42 Topics: Arrhythmias, Cardiac; Basal Ganglia Diseases; Depression; Female; Gastrointestinal Diseases; Humans; Hypotension, Orthostatic; Levodopa; Male; Nausea; Parkinson Disease, Secondary; Psychoses, Substance-Induced; Sex Factors; Time Factors; Vomiting	1975
The management of the levodopa psychoses. Clinical neuropharmacology, 1991, Volume: 14, Issue:4 Topics: Antipsychotic Agents; Electroconvulsive Therapy; Humans; Levodopa; Psychoses, Substance-Induced	1991
Motor complications associated with chronic levodopa therapy in Parkinson's disease. Neurology, 1989, Volume: 39, Issue:11 Suppl 2 Topics: Dementia; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease; Psychomotor Performance; Psychoses, Substance-Induced	1989

Trials

12 trial(s) available for levodopa and Psychoses, Drug

Article	Year
A single dose of L-DOPA changes perceptual experiences and decreases latent inhibition in Parkinson's disease. Journal of neural transmission (Vienna, Austria : 1996), 2017, Volume: 124, Issue:1 Topics: Antiparkinson Agents; Attention; Female; Humans; Inhibition, Psychological; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Perception; Psychoses, Substance-Induced	2017
Dopaminergic modulation of rapid reality adaptation in thinking. Neuroscience, 2010, May-19, Volume: 167, Issue:3 Topics: Adaptation, Psychological; Adult; Brain; Cognition Disorders; Dopamine; Dopamine Agents; Dopamine Antagonists; Double-Blind Method; Humans; Levodopa; Male; Memory; Memory Disorders; Mental Processes; Neural Inhibition; Neuropsychological Tests; Psychoses, Substance-Induced; Risperidone	2010
Quetiapine improves psychotic symptoms and cognition in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:1 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Antipsychotic Agents; Brief Psychiatric Rating Scale; Delusions; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hallucinations; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Neuropsychological Tests; Parkinson Disease; Psychoses, Substance-Induced; Quetiapine Fumarate	2004
Clozapine in drug induced psychosis in Parkinson's disease: a randomised, placebo controlled study with open follow up. Journal of neurology, neurosurgery, and psychiatry, 2004, Volume: 75, Issue:5 Topics: Aged; Clozapine; Dose-Response Relationship, Drug; Double-Blind Method; Feasibility Studies; Female; Follow-Up Studies; GABA Antagonists; Humans; Levodopa; Male; Parkinson Disease; Prospective Studies; Psychoses, Substance-Induced	2004
Anti-parkinson drugs in the Batten-Spielmeyer-Vogt syndrome; a pilot trial. Clinical neurology and neurosurgery, 1982, Volume: 84, Issue:2 Topics: Adolescent; Adult; Amantadine; Antiparkinson Agents; Benserazide; Drug Combinations; Humans; Levodopa; Lipidoses; Psychoses, Substance-Induced; Syndrome	1982
Plasma clozapine levels and the treatment of L-DOPA-induced psychosis in Parkinson's disease. A high potency effect of clozapine. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1995, Volume: 12, Issue:1 Topics: Aged; Clozapine; Female; Humans; Levodopa; Male; Parkinson Disease; Psychoses, Substance-Induced	1995
Remoxipride in the treatment of levodopa-induced psychosis. Journal of clinical psychopharmacology, 1996, Volume: 16, Issue:5 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Dopamine Antagonists; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease; Psychoses, Substance-Induced; Remoxipride	1996
Risperidone in levodopa-induced psychosis in advanced Parkinson's disease: an open-label, long-term study. Movement disorders : official journal of the Movement Disorder Society, 1997, Volume: 12, Issue:4 Topics: Aged; Antipsychotic Agents; Disease Progression; Female; Follow-Up Studies; Humans; Levodopa; Male; Parkinson Disease; Psychoses, Substance-Induced; Risperidone; Severity of Illness Index; Time Factors	1997
Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:3 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Antipsychotic Agents; Brief Psychiatric Rating Scale; Dibenzothiazepines; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced; Quetiapine Fumarate; Severity of Illness Index	1999
[Usefulness of olanzapine in the levodopa-induced psychosis in patients with Parkinson's disease]. Neurologia (Barcelona, Spain), 2002, Volume: 17, Issue:1 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Female; Humans; Levodopa; Male; Middle Aged; Olanzapine; Parkinson Disease; Pirenzepine; Prospective Studies; Psychoses, Substance-Induced	2002
Quetiapine for psychosis in Parkinson's disease versus dementia with Lewy bodies. The Journal of clinical psychiatry, 2002, Volume: 63, Issue:6 Topics: Aged; Antipsychotic Agents; Dibenzothiazepines; Humans; Levodopa; Lewy Body Disease; Parkinson Disease; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Quetiapine Fumarate; Retrospective Studies; Severity of Illness Index; Treatment Outcome	2002
Effect of CB 154 (2-bromo-alpha-ergocryptine) on paralysis agitans compared with Madopar in a double-blind, cross-over trial. Acta neurologica Scandinavica, 1976, Volume: 53, Issue:3 Topics: Aged; Azides; Benserazide; Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Combinations; Ergolines; Female; Humans; Hydrazines; Hyperkinesis; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Psychoses, Substance-Induced	1976

Other Studies

93 other study(ies) available for levodopa and Psychoses, Drug

Article	Year
Selective metabotropic glutamate receptor 2 positive allosteric modulation alleviates L-DOPA-induced psychosis-like behaviours and dyskinesia in the MPTP-lesioned marmoset. European journal of pharmacology, 2020, Apr-15, Volume: 873 Topics: Animals; Antiparkinson Agents; Antipsychotic Agents; Behavior, Animal; Callithrix; Dyskinesia, Drug-Induced; Female; GABA Modulators; Levodopa; Male; MPTP Poisoning; Parkinson Disease; Psychoses, Substance-Induced; Pyridines; Receptors, Metabotropic Glutamate; Sulfonamides	2020
Monoamine oxidase A inhibition with moclobemide enhances the anti-parkinsonian effect of L-DOPA in the MPTP-lesioned marmoset. Naunyn-Schmiedeberg's archives of pharmacology, 2020, Volume: 393, Issue:11 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Basal Ganglia; Behavior, Animal; Callithrix; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Levodopa; Male; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Motor Activity; Parkinsonian Disorders; Psychoses, Substance-Induced	2020
Nefazodone reduces dyskinesia, but not psychosis-like behaviours, in the parkinsonian marmoset. Naunyn-Schmiedeberg's archives of pharmacology, 2018, Volume: 391, Issue:12 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Behavior, Animal; Callithrix; Dyskinesia, Drug-Induced; Female; Levodopa; Male; Parkinsonian Disorders; Piperazines; Psychoses, Substance-Induced; Triazoles	2018
Dopamine dysregulation syndrome with psychosis in 24-hour intestinal levodopa infusion for Parkinson's disease. Parkinsonism & related disorders, 2016, Volume: 28 Topics: Antiparkinson Agents; Antipsychotic Agents; Brain Diseases, Metabolic; Capgras Syndrome; Clozapine; Dopamine; Hallucinations; Humans; Infusions, Parenteral; Levodopa; Male; Middle Aged; Psychoses, Substance-Induced	2016
The effect of mirtazapine on dopaminergic psychosis and dyskinesia in the parkinsonian marmoset. Psychopharmacology, 2017, Volume: 234, Issue:6 Topics: Animals; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Behavior, Animal; Callithrix; Dyskinesia, Drug-Induced; Female; Levodopa; Male; Mianserin; Mirtazapine; Motor Activity; MPTP Poisoning; Parkinsonian Disorders; Psychoses, Substance-Induced	2017
Use of clozapine in Brazilian patients with Parkinson's disease. Arquivos de neuro-psiquiatria, 2008, Volume: 66, Issue:3B Topics: Adult; Aged; Antiparkinson Agents; Antipsychotic Agents; Clozapine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced; Retrospective Studies	2008
Fatty acid amide hydrolase (FAAH) inhibition reduces L-3,4-dihydroxyphenylalanine-induced hyperactivity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned non-human primate model of Parkinson's disease. The Journal of pharmacology and experimental therapeutics, 2011, Volume: 336, Issue:2 Topics: Amides; Amidohydrolases; Animals; Benzamides; Callithrix; Carbamates; Disease Models, Animal; Dyskinesia, Drug-Induced; Endocannabinoids; Enzyme Inhibitors; Ethanolamines; Female; Levodopa; Motor Activity; MPTP Poisoning; Oleic Acids; Palmitic Acids; Psychoses, Substance-Induced	2011
Parkinsonism with multiple cysts in the bilateral striata. Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, 2011, Volume: 11, Issue:3 Topics: 3-Iodobenzylguanidine; Aged; Antiparkinson Agents; Antipsychotic Agents; Brain Ischemia; Delirium; Delusions; Diagnosis, Differential; Dibenzothiazepines; Dominance, Cerebral; Drug Therapy, Combination; Encephalomalacia; Hallucinations; Humans; Levodopa; Magnetic Resonance Imaging; Male; Neostriatum; Neurologic Examination; Organophosphate Poisoning; Parkinsonian Disorders; Psychoses, Substance-Induced; Quetiapine Fumarate; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed	2011
The effects of fast-off-D2 receptor antagonism on L-DOPA-induced dyskinesia and psychosis in parkinsonian macaques. Progress in neuro-psychopharmacology & biological psychiatry, 2013, Jun-03, Volume: 43 Topics: Animals; Antiparkinson Agents; Behavior, Animal; Butyrophenones; Cloning, Molecular; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dyskinesia, Drug-Induced; Female; Levodopa; Macaca fascicularis; Male; MPTP Poisoning; Parkinson Disease, Secondary; Psychoses, Substance-Induced	2013
The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia. Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:4 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Mental Status Schedule; Middle Aged; Motor Skills; Neurologic Examination; Parkinson Disease; Psychoses, Substance-Induced; Quetiapine Fumarate; Retrospective Studies	2002
[Levodopa dependency in Parkinson's disease: case report and review]. Der Nervenarzt, 2002, Volume: 73, Issue:9 Topics: Adult; Antiparkinson Agents; Combined Modality Therapy; Diagnosis, Differential; Dose-Response Relationship, Drug; Humans; Levodopa; Limbic System; Male; Mental Status Schedule; Mesencephalon; Neurologic Examination; Parkinson Disease; Patient Care Team; Psychoses, Substance-Induced; Receptors, Dopamine; Substance-Related Disorders	2002
Olanzapine: a proarrhythmic drug? Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2002, Volume: 47, Issue:7 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Carbidopa; Electrocardiography; Female; Humans; Levodopa; Long QT Syndrome; Olanzapine; Pirenzepine; Psychoses, Substance-Induced; Risk Factors	2002
[Hallucinations in Parkinson's disease]. Der Nervenarzt, 2003, Volume: 74, Issue:4 Topics: Antiparkinson Agents; Brain; Diagnosis, Differential; Dopamine Agonists; Hallucinations; Humans; Levodopa; Parkinson Disease; Psychoses, Substance-Induced; Risk Factors	2003
L -dopa-induced adverse effects in PD and dopamine transporter gene polymorphism. Neurology, 2003, Jun-10, Volume: 60, Issue:11 Topics: Aged; Antiparkinson Agents; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Parkinson Disease; Polymorphism, Genetic; Psychoses, Substance-Induced; Receptors, Dopamine; Retrospective Studies	2003
[Three patients with Parkinson's disease whose therapeutic levels were successfully improved after administration of quetiapine for suppression of psychosis]. No to shinkei = Brain and nerve, 2003, Volume: 55, Issue:5 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Cabergoline; Dibenzothiazepines; Ergolines; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced; Quetiapine Fumarate	2003
GPi pallidotomy for Parkinson's disease with drug-induced psychosis. Parkinsonism & related disorders, 2003, Volume: 10, Issue:1 Topics: Adult; Aged; Female; Globus Pallidus; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Postoperative Period; Preoperative Care; Psychoses, Substance-Induced; Regression Analysis; Retrospective Studies; Statistics, Nonparametric	2003
Aripiprazole and Parkinson's disease psychosis. The American journal of psychiatry, 2004, Volume: 161, Issue:2 Topics: Aged; Antipsychotic Agents; Aripiprazole; Dopamine Agonists; Dose-Response Relationship, Drug; Humans; Levodopa; Male; Parkinson Disease; Piperazines; Psychoses, Substance-Induced; Quinolones	2004
Ziprasidone in Parkinson's disease psychosis. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2004, Volume: 49, Issue:1 Topics: Aged; Antipsychotic Agents; Dopamine Agonists; Humans; Levodopa; Male; Parkinson Disease; Piperazines; Psychoses, Substance-Induced; Thiazoles	2004
The two faces of L-DOPA: benefits and adverse side effects in the treatment of Encephalitis lethargica, Parkinson's disease, multiple sclerosis and amyotrophic lateral sclerosis. Medical hypotheses, 2004, Volume: 62, Issue:2 Topics: Amyotrophic Lateral Sclerosis; Antioxidants; Antiparkinson Agents; Dopamine Agents; Dyskinesia, Drug-Induced; Gastrointestinal Diseases; Hallucinations; Humans; Levodopa; Multiple Sclerosis; Oxidative Stress; Parkinson Disease; Parkinson Disease, Postencephalitic; Psychoses, Substance-Induced; Sleep Initiation and Maintenance Disorders; Vitamin B Complex	2004
Factors associated with drug-induced visual hallucinations in Parkinson's disease. Journal of neurology, 2005, Volume: 252, Issue:10 Topics: Age of Onset; Aged; Antiparkinson Agents; Female; Greece; Hallucinations; Humans; Interviews as Topic; Levodopa; Logistic Models; Male; Middle Aged; Parkinson Disease; Prevalence; Psychoses, Substance-Induced; Risk Factors; Severity of Illness Index; Statistics, Nonparametric; Visual Acuity	2005
Electroconvulsive therapy in drug-induced psychiatric states and neuroleptic malignant syndrome. The journal of ECT, 2005, Volume: 21, Issue:2 Topics: Antiparkinson Agents; Dopamine Agents; Drug Administration Schedule; Electroconvulsive Therapy; Female; Humans; Levodopa; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Psychoses, Substance-Induced	2005
The first evaluation of brain shift during functional neurosurgery by deformation field analysis. Journal of neurology, neurosurgery, and psychiatry, 2005, Volume: 76, Issue:8 Topics: Aged; Antiparkinson Agents; Deep Brain Stimulation; Dyskinesias; Electrodes, Implanted; Gait; Humans; Imaging, Three-Dimensional; Intraoperative Care; Levodopa; Magnetic Resonance Imaging; Male; Microelectrodes; Movement Disorders; Neurosurgical Procedures; Parkinson Disease; Psychoses, Substance-Induced; Radiosurgery; Subthalamic Nucleus	2005
Levodopa addiction in idiopathic Parkinson disease. Neurology, 2005, Nov-08, Volume: 65, Issue:9 Topics: Aged; Bipolar Disorder; Dopamine Agents; Dyskinesia, Drug-Induced; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced; Quadriplegia; Spinal Cord Diseases; Substance-Related Disorders	2005
Treatment of drug-induced psychosis in Parkinson's disease with ziprasidone can induce severe dose-dependent off-periods and pathological laughing. Clinical neurology and neurosurgery, 2007, Volume: 109, Issue:2 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Clozapine; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Laughter; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Parkinson Disease, Secondary; Piperazines; Psychoses, Substance-Induced; Quetiapine Fumarate; Thiazoles	2007
Genetic polymorphism of the angiotensin converting enzyme and L-dopa-induced adverse effects in Parkinson's disease. Journal of the neurological sciences, 2007, Jan-31, Volume: 252, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Dyskinesia, Drug-Induced; Female; Genetic Predisposition to Disease; Homozygote; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Predictive Value of Tests; Psychoses, Substance-Induced; Risk Factors	2007
Ziprasidone for drug-induced psychotic symptoms in Parkinson's Disease. Progress in neuro-psychopharmacology & biological psychiatry, 2008, Feb-15, Volume: 32, Issue:2 Topics: Acute Disease; Antipsychotic Agents; Brief Psychiatric Rating Scale; Carbidopa; Drug Combinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Piperazines; Psychoses, Substance-Induced; Thiazoles	2008
Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease. Acta neurochirurgica, 2008, Volume: 150, Issue:1 Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Deep Brain Stimulation; Dyskinesias; Electrodes, Implanted; Female; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Posture; Psychoses, Substance-Induced; Retrospective Studies; Subthalamic Nucleus; Tremor	2008
Acute overdose with controlled-release levodopa-carbidopa. Clinical toxicology (Philadelphia, Pa.), 2008, Volume: 46, Issue:3 Topics: Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Dopamine; Drug Combinations; Drug Overdose; Epinephrine; Humans; Kinetics; Levodopa; Male; Middle Aged; Norepinephrine; Psychomotor Agitation; Psychoses, Substance-Induced; Tachycardia	2008
Symptoms and side effects in the course of Parkinson's disease. Journal of neural transmission. Supplementum, 1983, Volume: 19 Topics: Autonomic Nervous System Diseases; Dementia; Diagnosis, Differential; Dopamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Levodopa; Movement Disorders; Muscle Rigidity; Parkinson Disease; Psychoses, Substance-Induced; Receptors, Dopamine	1983
What to do when Sinemet fails: Part one. Clinical neuropharmacology, 1984, Volume: 7, Issue:2 Topics: Antiparkinson Agents; Carbidopa; Dementia; Drug Administration Schedule; Drug Combinations; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease; Psychoses, Substance-Induced	1984
[Exogenous psychoses in Parkinson syndrome. Frequency and causal conditions]. Fortschritte der Neurologie-Psychiatrie, 1984, Volume: 52, Issue:6 Topics: Adult; Aged; Antiparkinson Agents; Brain; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced; Receptors, Dopamine; Risk	1984
Levodopa: long-term impact on Parkinson's disease. British medical journal (Clinical research ed.), 1981, Feb-07, Volume: 282, Issue:6262 Topics: Atrophy; Cerebral Cortex; Dementia; Hallucinations; Humans; Levodopa; Parkinson Disease; Psychoses, Substance-Induced	1981
Use of lisuride in advanced Parkinson's disease. Potent dopamine and serotonin agonist. New York state journal of medicine, 1981, Volume: 81, Issue:12 Topics: Aged; Ergolines; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced	1981
Behavioral alterations and the therapy of parkinsonism. Clinical neuropharmacology, 1982, Volume: 5 Suppl 1 Topics: Bipolar Disorder; Bromocriptine; Dementia; Depressive Disorder; Humans; Levodopa; Mental Processes; Parkinson Disease; Psychoses, Substance-Induced	1982
Sleep disruption in the course of chronic levodopa therapy: an early feature of the levodopa psychosis. Clinical neuropharmacology, 1982, Volume: 5, Issue:2 Topics: Aged; Bromocriptine; Carbidopa; Dreams; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced; Sleep Initiation and Maintenance Disorders; Sleep Stages	1982
Treatment with tryptophan of levodopa-associated psychiatric disturbances. Archives of neurology, 1980, Volume: 37, Issue:3 Topics: Aged; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Tryptophan	1980
[Clinical aspects and follow-up of dopamine-induced psychoses in continuous dopaminergic therapy and their implications for the dopamine hypothesis of schizophrenic symptoms]. Der Nervenarzt, 1995, Volume: 66, Issue:9 Topics: Aged; Brain; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infusion Pumps; Levodopa; Lisuride; Male; Middle Aged; Neurologic Examination; Neuropsychological Tests; Parkinson Disease; Psychoses, Substance-Induced; Schizophrenia; Schizophrenic Psychology; Synaptic Transmission	1995
Clozapine therapeutic plunge in patient with Parkinson's disease. Lancet (London, England), 1995, May-06, Volume: 345, Issue:8958 Topics: Carbidopa; Clozapine; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced; Psychotic Disorders	1995
Zotepine reversibly induces akinesia and rigidity in Parkinson's disease patients with resting tremor or drug-induced psychosis. Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:2 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Dibenzothiepins; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Muscle Rigidity; Neurologic Examination; Parkinson Disease; Psychoses, Substance-Induced; Tremor	1994
Old-onset Parkinson's disease compared with young-onset disease: clinical differences and similarities. Acta neurologica Scandinavica, 1994, Volume: 89, Issue:4 Topics: Activities of Daily Living; Adult; Age Factors; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Psychoses, Substance-Induced	1994
Treatment of organic bipolar mood disorders in Parkinson's disease. The Journal of neuropsychiatry and clinical neurosciences, 1994,Spring, Volume: 6, Issue:2 Topics: Bipolar Disorder; Clozapine; Drug Therapy, Combination; Female; Humans; Levodopa; Lithium Carbonate; Male; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced; Recurrence	1994
Symptomatic relief from treatment-induced psychosis in Parkinson's disease: an open-label pilot study with remoxipride. Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:2 Topics: Aged; Aged, 80 and over; Carbidopa; Drug Therapy, Combination; Female; Humans; Levodopa; Limbic System; Long-Term Care; Male; Mesencephalon; Middle Aged; Parkinson Disease; Pilot Projects; Psychoses, Substance-Induced; Receptors, Dopamine D2; Remoxipride	1994
Antecedent clinical features associated with dementia in Parkinson's disease. Neurology, 1993, Volume: 43, Issue:9 Topics: Aged; Dementia; Depression; Humans; Levodopa; Middle Aged; Odds Ratio; Parkinson Disease; Prevalence; Psychoses, Substance-Induced; Risk Factors	1993
Treatment of drug-induced psychosis in Parkinson's disease with clozapine. Advances in neurology, 1993, Volume: 60 Topics: Aged; Antiparkinson Agents; Carbidopa; Clozapine; Dementia; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Psychoses, Substance-Induced	1993
L-DOPA and psychosis: evidence for L-DOPA-induced increases in prefrontal cortex dopamine and in serum corticosterone. Biological psychiatry, 1995, Nov-15, Volume: 38, Issue:10 Topics: Animals; Antiparkinson Agents; Corpus Striatum; Corticosterone; Dopamine; Homovanillic Acid; Levodopa; Male; Prefrontal Cortex; Psychoses, Substance-Induced; Rats; Rats, Sprague-Dawley; Regression Analysis; Risk Factors	1995
Therapeutic dilemma: psychosis and Parkinson's disease. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1995, Volume: 40, Issue:10 Topics: Aged; Antiparkinson Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Levodopa; Male; Neurologic Examination; Parkinson Disease; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Risperidone	1995
Zotepine in levodopa-induced Psychosis. Movement disorders : official journal of the Movement Disorder Society, 1995, Volume: 10, Issue:6 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Antipsychotic Agents; Dibenzothiepins; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced	1995
Ondansetron treatment of L-dopa-induced psychosis. Neurology, 1996, Volume: 47, Issue:6 Topics: Aged; Female; Humans; Levodopa; Male; Middle Aged; Ondansetron; Psychoses, Substance-Induced	1996
Use of clozapine to treat levodopa-induced psychosis in Parkinson's disease: retrospective review. Journal of geriatric psychiatry and neurology, 1997, Volume: 10, Issue:2 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Clozapine; Female; Humans; Levodopa; Long-Term Care; Male; Parkinson Disease; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Retrospective Studies; Treatment Outcome	1997
Psychosis during chronic levodopa therapy triggered by the new antidepressive drug mirtazapine. Pharmacopsychiatry, 1997, Volume: 30, Issue:6 Topics: Adult; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Depressive Disorder; Drug Interactions; Female; Humans; Levodopa; Mianserin; Mirtazapine; Parkinson Disease; Psychoses, Substance-Induced; Suicide, Attempted	1997
[Levodopa-induced psychosis in patients with idiopathic Parkinson disease]. Medicina clinica, 1999, Feb-27, Volume: 112, Issue:7 Topics: Aged; Antiparkinson Agents; Dose-Response Relationship, Drug; Female; Humans; Levodopa; Male; Middle Aged; Multivariate Analysis; Parkinson Disease; Patient Selection; Psychoses, Substance-Induced; Retrospective Studies; Risk Factors	1999
Worsening of motor features of parkinsonism with olanzapine. Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:6 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Neurologic Examination; Olanzapine; Parkinson Disease; Parkinson Disease, Secondary; Pirenzepine; Psychoses, Substance-Induced; Risk Factors	1999
Quetiapine for l-dopa-induced psychosis in PD. Neurology, 2000, Apr-11, Volume: 54, Issue:7 Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Humans; Levodopa; Male; Olanzapine; Parkinson Disease; Pirenzepine; Psychoses, Substance-Induced; Quetiapine Fumarate; Treatment Outcome	2000
Quetiapine for l-dopa-induced psychosis in PD. Neurology, 2000, Sep-26, Volume: 55, Issue:6 Topics: Antipsychotic Agents; Dibenzothiazepines; Humans; Levodopa; Parkinson Disease; Pirenzepine; Psychoses, Substance-Induced	2000
[A case of delusional jealousy in Parkinson disease ]. Der Nervenarzt, 2001, Volume: 72, Issue:3 Topics: Antiparkinson Agents; Benserazide; Delusions; Dose-Response Relationship, Drug; Drug Combinations; Humans; Jealousy; Levodopa; Male; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced	2001
The relationship between epilepsy and schizophrenia: a biochemical hypothesis. Biological psychiatry, 1977, Volume: 12, Issue:2 Topics: Amphetamines; Antipsychotic Agents; Brain; Dopamine; Epilepsy; Humans; Levodopa; Phenothiazines; Psychoses, Substance-Induced; Receptors, Dopamine; Schizophrenia	1977
[Acute pharmacotoxic psychoses in patients with chronic cerebral disorders]. Wiener medizinische Wochenschrift. Supplement, 1979, Volume: 55 Topics: Aged; Alzheimer Disease; Antidepressive Agents; Antipsychotic Agents; Brain Diseases; Cerebrovascular Disorders; Dementia; Digitalis Glycosides; Diuretics; Female; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Multiple Sclerosis; Parkinson Disease; Psychoses, Substance-Induced	1979
[Pharmacotoxic psychoses in patients with neurological disorders during old age (author's transl)]. Aktuelle Gerontologie, 1979, Volume: 9, Issue:9 Topics: Aged; Antidepressive Agents; Antiparkinson Agents; Antipsychotic Agents; Brain Diseases; Digitalis Glycosides; Diuretics; Humans; Levodopa; Middle Aged; Psychoses, Substance-Induced; Psychotropic Drugs	1979
Dream phenomena induced by chronic levodopa therapy. Journal of neural transmission, 1978, Volume: 43, Issue:2 Topics: Adult; Aged; Carbidopa; Delusions; Dreams; Female; Hallucinations; Humans; Illusions; Levodopa; Long-Term Care; Male; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced	1978
Behavioral side effects of medical drugs. Primary care, 1979, Volume: 6, Issue:2 Topics: Adrenal Cortex Hormones; Aged; Antihypertensive Agents; Antitubercular Agents; Aspirin; Behavior; Caffeine; Cimetidine; Contraceptives, Oral, Hormonal; Digitalis Glycosides; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Levodopa; Male; Mental Disorders; Parasympatholytics; Placebos; Propranolol; Psychoses, Substance-Induced; Reserpine; Sympathomimetics; Thyroid Hormones	1979
[Acute psychotic status after sudden interruption of treatment of Parkinsonism with levodopa]. Neurologija, 1977, Volume: 25, Issue:1-2 Topics: Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced	1977
Levodopa-induced psychosis: a kindling phenomenon. The American journal of psychiatry, 1978, Volume: 135, Issue:6 Topics: Adult; Aged; Chronic Disease; Confusion; Corpus Striatum; Delusions; Dreams; Female; Hallucinations; Humans; Levodopa; Limbic System; Male; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced; Receptors, Dopamine; Stimulation, Chemical; Time Factors	1978
Secondary mania: manic syndromes associated with antecedent physical illness or drugs. Archives of general psychiatry, 1978, Volume: 35, Issue:11 Topics: Adrenal Cortex Hormones; Adult; Bipolar Disorder; Bromides; Epilepsy, Temporal Lobe; Humans; Isoniazid; Levodopa; Middle Aged; Neoplasms; Neurocognitive Disorders; Postoperative Complications; Procarbazine; Psychomotor Agitation; Psychoses, Substance-Induced; Psychotropic Drugs; Renal Dialysis	1978
[Treatment of Parkinson's disease with the combination drug L-carbidopa/L-dopa. Report on a 2 years study]. Schweizerische medizinische Wochenschrift, 1977, Apr-09, Volume: 107, Issue:14 Topics: Carbidopa; Drug Combinations; Drug Evaluation; Female; Humans; Hydrazines; Levodopa; Male; Movement Disorders; Parkinson Disease; Psychoses, Substance-Induced	1977
Response to lithium in a case of L-dopa-induced psychosis. The American journal of psychiatry, 1977, Volume: 134, Issue:7 Topics: Humans; Levodopa; Lithium; Male; Middle Aged; Parkinson Disease; Personality; Psychoses, Substance-Induced	1977
Clinical response to several dopamine agonists in schizophrenic and nonschizophrenic subjects. Advances in biochemical psychopharmacology, 1977, Volume: 16 Topics: Amphetamine; Dextroamphetamine; Dopamine; Humans; Levodopa; Male; Paranoid Disorders; Piribedil; Psychoses, Substance-Induced; Schizophrenia	1977
Biochemical factors in Schizophrenia. Hospital practice, 1977, Volume: 12, Issue:10 Topics: Amphetamines; Animals; Binding Sites; Brain; Cocaine; Dopamine; Humans; Levodopa; Parkinson Disease, Secondary; Psychoses, Substance-Induced; Receptors, Dopamine; Schizophrenia; Tranquilizing Agents	1977
Psychiatric symptoms with initiation of carbidopa-levodopa treatment. Neurology, 1976, Volume: 26, Issue:7 Topics: Aged; Carbidopa; Drug Therapy, Combination; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced	1976
[A case of mental change resulting from L-dopa treatment]. Ugeskrift for laeger, 1976, Oct-04, Volume: 138, Issue:41 Topics: Aged; Diagnostic Errors; Humans; Levodopa; Male; Parkinson Disease; Psychoses, Substance-Induced; Tremor	1976
[Review of problems in the treatment of the parkinsonian syndrome with L-dopa]. La Clinica terapeutica, 1976, Mar-15, Volume: 76, Issue:5 Topics: Arrhythmias, Cardiac; Cardiovascular Diseases; Gastrointestinal Diseases; Humans; Hypertension; Hypotension, Orthostatic; Levodopa; Movement Disorders; Parkinson Disease, Secondary; Psychoses, Substance-Induced	1976
Amphetamine-induced dopaminergic hypersensitivity in guinea pigs. Implications in psychosis and human movement disorders. Archives of general psychiatry, 1975, Volume: 32, Issue:6 Topics: Amphetamine; Animals; Apomorphine; Behavior; Behavior, Animal; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Guinea Pigs; Humans; Levodopa; Movement Disorders; Psychoses, Substance-Induced; Reaction Time; Receptors, Drug; Schizophrenia; Stereotyped Behavior; Substance-Related Disorders	1975
Dopaminergic supersensitivity in parkinsonism. Advances in neurology, 1975, Volume: 9 Topics: Aged; Benzyl Compounds; Brain; Brain Chemistry; Dopamine; Drug Therapy, Combination; Female; Humans; Hydrazines; Hydroxyindoleacetic Acid; Levodopa; Nerve Degeneration; Norepinephrine; Parkinson Disease; Psychoses, Substance-Induced; Serotonin; Tryptophan; Tyrosine	1975
Responsibility of extrastriatal areas for the appearance of psychotic symptoms (clinical and biochemical human post-mortem findings). Journal of neural transmission, 1975, Volume: 37, Issue:2 Topics: Brain; Brain Mapping; Dihydroxyphenylalanine; Dopamine; Humans; Levodopa; Parkinson Disease; Psychoses, Substance-Induced	1975
Drugs, diagnosis, and disease. Research publications - Association for Research in Nervous and Mental Disease, 1975, Volume: 54 Topics: Acetylcholine; Amphetamines; Bipolar Disorder; Humans; Imipramine; Levodopa; Lithium; Methylphenidate; Monoamine Oxidase Inhibitors; Psychoses, Substance-Induced; Schizophrenia; Time Factors	1975
The dopamine hypothesis of schizophrenia. A critical analysis. Neuropsychobiology, 1975, Volume: 1, Issue:6 Topics: Acetylcholine; Amphetamine; Apomorphine; Cocaine; Dopamine; Electroconvulsive Therapy; gamma-Aminobutyric Acid; Humans; Levodopa; Methyldopa; Methyltyrosines; Models, Neurological; Psychoses, Substance-Induced; Schizophrenia; Tranquilizing Agents	1975
[L-dopa-decarboxylase inhibitor combination preparation (Sinemet) in parkinsonism and syndromes imitating parkinsonism. 1 year's experience with 34 patients]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1976, Feb-10, Volume: 96, Issue:4 Topics: Aged; Drug Combinations; Female; Humans; Levodopa; Male; Metoclopramide; Middle Aged; Nausea; Parkinson Disease; Psychoses, Substance-Induced; Vomiting	1976
[Psychiatric side-effects of levodopa treatment]. Ugeskrift for laeger, 1976, Apr-26, Volume: 138, Issue:18 Topics: Humans; Levodopa; Psychoses, Substance-Induced	1976
Clozapine prevents recurrence of psychosis in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 1992, Volume: 7, Issue:2 Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Clozapine; Dopamine Agents; Dose-Response Relationship, Drug; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Sleep Stages	1992
[Clozapine, a valuable contribution for the treatment of psychoses in Parkinson disease]. Lakartidningen, 1992, Dec-02, Volume: 89, Issue:49 Topics: Aged; Bromocriptine; Clozapine; Drug Therapy, Combination; Humans; Levodopa; Male; Parkinson Disease; Psychoses, Substance-Induced	1992
Clozapine for the treatment of levodopa-induced psychosis in Parkinson's disease. General hospital psychiatry, 1992, Volume: 14, Issue:4 Topics: Antiparkinson Agents; Carbidopa; Clozapine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Humans; Levodopa; Male; Middle Aged; Paranoid Disorders; Parkinson Disease; Psychoses, Substance-Induced	1992
Psychotic complications of long-term levodopa treatment of Parkinson's disease. Acta neurologica Scandinavica, 1991, Volume: 84, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Long-Term Care; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Psychoses, Substance-Induced	1991
Early-onset Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 1991, Volume: 6, Issue:1 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Dementia; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Psychoses, Substance-Induced; Risk Factors	1991
A therapeutic approach to tardive dyskinesia. The Journal of clinical psychiatry, 1985, Volume: 46, Issue:4 Pt 2 Topics: Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Colitis; Depressive Disorder; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Methyltyrosines; Middle Aged; Nausea; Paranoid Disorders; Psychomotor Agitation; Psychoses, Substance-Induced; Psychotic Disorders; Receptors, Dopamine; Reserpine; Tetrabenazine; Time Factors	1985
Treatment of drug-induced exogenous psychosis in parkinsonism with clozapine and fluperlapine. European archives of psychiatry and neurological sciences, 1985, Volume: 235, Issue:1 Topics: Aged; Antipsychotic Agents; Benserazide; Bromocriptine; Clozapine; Delusions; Dibenzazepines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hallucinations; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced; Tryptophan	1985
Psychosis and the lisuride pump. Lancet (London, England), 1986, Aug-09, Volume: 2, Issue:8502 Topics: Drug Therapy, Combination; Ergolines; Humans; Infusions, Parenteral; Levodopa; Lisuride; Parkinson Disease; Psychoses, Substance-Induced	1986
Levodopa addiction. A case study. Acta psychiatrica Scandinavica, 1988, Volume: 78, Issue:3 Topics: Adult; Dermatitis, Seborrheic; Dose-Response Relationship, Drug; Female; Humans; Levodopa; Muscle Rigidity; Paranoid Disorders; Parkinson Disease, Secondary; Psychoses, Substance-Induced; Risk Factors; Substance Withdrawal Syndrome; Substance-Related Disorders	1988
[L-dopa-induced psychoses and their treatment with L-tryptophan]. Fortschritte der Medizin, 1986, Apr-30, Volume: 104, Issue:17 Topics: Humans; Levodopa; Parkinson Disease; Psychoses, Substance-Induced; Tryptophan	1986
Transdihydrolisuride in parkinsonism. Clinical neuropharmacology, 1987, Volume: 10, Issue:1 Topics: Aged; Blood Pressure; Ergolines; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Movement Disorders; Nausea; Parkinson Disease; Psychoses, Substance-Induced	1987
Parkinson disease. Individualizing therapy. Hospital practice (Office ed.), 1985, Jan-15, Volume: 20, Issue:1 Topics: Aged; Bromocriptine; Carbidopa; Central Nervous System Diseases; Diagnosis, Differential; Gait; Humans; Levodopa; Male; Motor Activity; Parkinson Disease; Psychoses, Substance-Induced; Tremor	1985
The treatment of Parkinson's disease. The Medical journal of Australia, 1985, Oct-14, Volume: 143, Issue:8 Topics: Aged; Bromocriptine; Carboxy-Lyases; Humans; Levodopa; Movement Disorders; Nausea; Parkinson Disease; Psychoses, Substance-Induced	1985
[The problem of side effects after a treatment with L-dopa in the Parkinson's syndrome: clinical and animal studies (author's transl)]. Folia clinica internacional, 1974, Volume: 24, Issue:10 Topics: Adult; Aged; Brain; Cardiovascular Diseases; Dopamine; Drug Eruptions; Female; Gastrointestinal Diseases; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Pain; Paresthesia; Parkinson Disease, Secondary; Psychoses, Substance-Induced	1974
Levodopa, manganese, and degenerations of the brain. Harvey lectures, 1974, Volume: 68 Topics: Administration, Oral; Animals; Apomorphine; Blood Urea Nitrogen; Brain Diseases; Carbon Radioisotopes; Chemical Phenomena; Chemistry; Chronic Disease; Dietary Proteins; Dopamine; Drug Therapy, Combination; Growth Hormone; Humans; Injections; Levodopa; Manganese Poisoning; Movement Disorders; Neutron Activation Analysis; Parkinson Disease; Psychoses, Substance-Induced; Radioisotopes	1974
Psychiatric aspects of L-dopa therapy of Parkinson's disease. Psychiatry in medicine, 1972, Volume: 3, Issue:1 Topics: Adult; Aged; Delirium; Depression; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced	1972